Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jorge
    Member
    • Jun 2011
    • 25

    #1

    GATK 'Variant quality score recalibration' for shallow coverage

    Hello,

    I've used GATK to produce variant calls (VCF files). I have shallow coverage (<10) and the documentation suggests using 'Variant quality score recalibration' according to 'true sites' from HapMap 3 and Omni 2.5M SNP chip array. My question is, will I loose all the variants not occuring on those controls? For example, will I loose novel variant?

    any advise on this is welcome

    Thanks
    Jorge
  • mamons
    Member
    • Nov 2011
    • 10

    #2
    Hello,

    those sets with "true sites" are used to build an error model then each snp will be given a score based on the error model and the other parameters that has been collected.

    So you will not loose any information.

    Comment

    • jorge
      Member
      • Jun 2011
      • 25

      #3
      Hello!

      Thanks a lot for clarifying that!

      Jorge

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
        by SEQadmin2




        NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
        Today, 06:46 AM
      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-28-2026, 09:57 AM
      0 responses
      24 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-28-2026, 09:51 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 11:13 AM
      0 responses
      70 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-22-2026, 10:48 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...